Published in Mov Disord on September 15, 2010
Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design. Parkinsonism Relat Disord (2013) 2.05
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol (2013) 1.30
Retraining function in people with Parkinson's disease using the Microsoft kinect: game design and pilot testing. J Neuroeng Rehabil (2014) 1.03
Short- and long-term efficacy of intensive rehabilitation treatment on balance and gait in parkinsonian patients: a preliminary study with a 1-year followup. Parkinsons Dis (2013) 0.93
Review: management of Parkinson's disease. Neuropsychiatr Dis Treat (2013) 0.93
Exploring outcome measures for exercise intervention in people with Parkinson's disease. Parkinsons Dis (2013) 0.89
Two-year exercise program improves physical function in Parkinson's disease: the PRET-PD randomized clinical trial. Neurorehabil Neural Repair (2014) 0.89
Exercise and motor training in people with Parkinson's disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials. Parkinsons Dis (2011) 0.86
Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson's disease. J Neural Transm (Vienna) (2011) 0.82
Amplitude-oriented exercise in Parkinson's disease: a randomized study comparing LSVT-BIG and a short training protocol. J Neural Transm (Vienna) (2014) 0.81
Dynamic High-Cadence Cycling Improves Motor Symptoms in Parkinson's Disease. Front Neurol (2015) 0.79
An evidence-based exercise regimen for patients with mild to moderate Parkinson's disease. Brain Sci (2013) 0.79
Effect of exercise on motor and nonmotor symptoms of Parkinson's disease. Parkinsons Dis (2015) 0.79
Effects of amplitude cueing on postural responses and preparatory cortical activity of people with Parkinson disease. J Neurol Phys Ther (2014) 0.78
Parkinson's disease: recent advances. J Neurol (2014) 0.78
Adaptive training with full-body movements to reduce bradykinesia in persons with Parkinson's disease: a pilot study. J Neuroeng Rehabil (2015) 0.78
Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: a randomized clinical trial. BMC Neurol (2015) 0.78
The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease. Transl Neurodegener (2016) 0.77
LSVT-BIG Improves UPDRS III Scores at 4 Weeks in Parkinson's Disease Patients with Wearing Off: A Prospective, Open-Label Study. Parkinsons Dis (2017) 0.75
Postural Stability in Parkinson's Disease Patients Is Improved after Stochastic Resonance Therapy. Parkinsons Dis (2016) 0.75
On your feet: protocol for a randomized controlled trial to compare the effects of pole walking and regular walking on physical and psychosocial health in older adults. BMC Public Health (2014) 0.75
The effectiveness of physiotherapy treatment on balance dysfunction and postural instability in persons with Parkinson's disease: a systematic review and meta-analysis. BMC Sports Sci Med Rehabil (2016) 0.75
Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®. Rehabil Res Pract (2017) 0.75
Polestriding intervention improves gait and axial symptoms in mild to moderate Parkinson's disease. Arch Phys Med Rehabil (2016) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain (2004) 3.36
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol (2008) 3.00
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci (2008) 2.65
Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci (2006) 2.29
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol (2012) 1.93
Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur J Neurosci (2005) 1.85
The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease. Exp Neurol (2005) 1.83
Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp Neurol (2005) 1.59
Cortico-cortical coupling in Parkinson's disease and its modulation by therapy. Brain (2005) 1.49
Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging (2006) 1.46
Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol (2004) 1.45
Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain (2003) 1.40
Ocular flutter in a patient with intracranial hypertension following cerebral venous thrombosis. Neurology (2002) 1.39
Modulation of beta oscillations in the subthalamic area during motor imagery in Parkinson's disease. Brain (2005) 1.35
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol (2007) 1.34
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Occurence and clinical predictors of spasticity after ischemic stroke. Stroke (2010) 1.24
Genes associated with Parkinson syndrome. J Neurol (2008) 1.21
Elevations in local gamma activity are accompanied by changes in the firing rate and information coding capacity of neurons in the region of the subthalamic nucleus in Parkinson's disease. Exp Neurol (2006) 1.21
Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease. Arch Phys Med Rehabil (2008) 1.20
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord (2010) 1.18
Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease. Brain (2007) 1.16
The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus. Eur J Neurosci (2005) 1.15
Practical considerations for goal attainment scaling during rehabilitation following acquired brain injury. J Rehabil Med (2011) 1.14
Deep brain stimulation of the subthalamic nucleus: a two-edged sword. Curr Biol (2006) 1.13
Frequency dependent effects of subthalamic nucleus stimulation in Parkinson's disease. Neurosci Lett (2005) 1.11
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat. Exp Neurol (2002) 1.07
The human thalamus processes syntactic and semantic language violations. Neuron (2008) 1.07
Is the synchronization between pallidal and muscle activity in primary dystonia due to peripheral afferance or a motor drive? Brain (2008) 1.05
Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett (2002) 1.05
Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord (2011) 1.05
Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord (2007) 1.03
Behavioural cues are associated with modulations of synchronous oscillations in the human subthalamic nucleus. Brain (2003) 1.03
Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord (2008) 1.03
Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord (2010) 1.03
Gamma activity and reactivity in human thalamic local field potentials. Eur J Neurosci (2009) 1.01
Lesion of the medial prefrontal cortex and the subthalamic nucleus selectively affect depression-like behavior in rats. Behav Brain Res (2010) 1.00
The effects of electrode material, charge density and stimulation duration on the safety of high-frequency stimulation of the subthalamic nucleus in rats. J Neurosci Methods (2004) 1.00
Scaling of movement is related to pallidal γ oscillations in patients with dystonia. J Neurosci (2012) 0.99
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol Dis (2006) 0.99
Subthalamic gamma activity in patients with Parkinson's disease. Exp Neurol (2006) 0.99
Neuronal activity in globus pallidus interna can be synchronized to local field potential activity over 3-12 Hz in patients with dystonia. Exp Neurol (2006) 0.98
Long-Term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord (2011) 0.98
Paranoid schizophrenia and idiopathic Parkinson's disease do coexist: a challenge for clinicians. Psychiatry Clin Neurosci (2006) 0.97
Pathophysiology of spasticity in stroke. Neurology (2013) 0.97
Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke (2011) 0.97
Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson's disease. Eur J Neurosci (2005) 0.97
High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J Neurochem (2003) 0.97
Premovement activities in the subthalamic area of patients with Parkinson's disease and their dependence on task. Eur J Neurosci (2007) 0.96
Continuous high-frequency stimulation in freely moving rats: development of an implantable microstimulation system. J Neurosci Methods (2007) 0.95
Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord (2008) 0.94
High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat. Exp Brain Res (2007) 0.94
Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST). J Rehabil Med (2014) 0.93
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behav Brain Res (2007) 0.93
Task-related differential dynamics of EEG alpha- and beta-band synchronization in cortico-basal motor structures. Eur J Neurosci (2007) 0.93
Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Mov Disord (2011) 0.92
Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia (2010) 0.92
Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Mov Disord (2010) 0.92
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Mov Disord (2006) 0.91
Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. J Rehabil Med (2011) 0.90
Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease. Mov Disord (2011) 0.90
Increased beta activity in dystonia patients after drug-induced dopamine deficiency. Exp Neurol (2008) 0.90
High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci (2009) 0.90
Motor cortex inhibition induced by acoustic stimulation. Exp Brain Res (2004) 0.90
Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression. Exp Neurol (2013) 0.89
Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism. Exp Neurol (2007) 0.88
Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimul (2012) 0.88
Subthalamic stimulation differentially modulates declarative and nondeclarative memory. Neuroreport (2004) 0.88
Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov Disord (2008) 0.88
Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol (2005) 0.88
Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia. J Neurol Neurosurg Psychiatry (2013) 0.87
Myopathy causing camptocormia in idiopathic Parkinson's disease: a multidisciplinary approach. Mov Disord (2010) 0.87
Evidence-based quality indicators for stroke rehabilitation. Stroke (2011) 0.87
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry. J Neural Transm (Vienna) (2014) 0.87
Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J Neurol Sci (2011) 0.86
Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians). J Med Econ (2014) 0.86
A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis. BMJ Open (2011) 0.86
Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol (2006) 0.86
Mental chronometry of target detection: human thalamus leads cortex. Brain (2006) 0.86
Amplitude modulation of oscillatory activity in the subthalamic nucleus during movement. Eur J Neurosci (2008) 0.85
Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder. World J Biol Psychiatry (2010) 0.85
Comparison of motor effects following subcortical electrical stimulation through electrodes in the globus pallidus internus and cortical transcranial magnetic stimulation. Exp Brain Res (2003) 0.85
Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment? Int J Rehabil Res (2012) 0.85
Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord (2006) 0.84
Involvement of human internal globus pallidus in the early modulation of cortical error-related activity. Cereb Cortex (2013) 0.84
Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases. Mov Disord (2008) 0.83
Levodopa inhibits habit-learning in Parkinson’s disease. J Neural Transm (Vienna) (2014) 0.81
Amplitude-oriented exercise in Parkinson's disease: a randomized study comparing LSVT-BIG and a short training protocol. J Neural Transm (Vienna) (2014) 0.81
The human thalamus is crucially involved in executive control operations. J Cogn Neurosci (2008) 0.81
Activity modulation of the globus pallidus and the nucleus entopeduncularis affects compulsive checking in rats. Behav Brain Res (2011) 0.81
Frequency-specific effects of stimulation of the subthalamic area in treated Parkinson's disease patients. Neuroreport (2009) 0.81
Frequency-dependent distribution of local field potential activity within the subthalamic nucleus in Parkinson's disease. Exp Neurol (2007) 0.81
High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study. Arch Gerontol Geriatr (2005) 0.80
High-frequency stimulation of the entopeduncular nucleus improves dystonia in dtsz hamsters. Neuroreport (2004) 0.80
Risk of tissue damage and deep brain stimulation with external devices: A technical note. Ann Neurol (2004) 0.80